Serramend
En vente sur le marché américain (selon le DSLD)
Health Concerns, food supplement from the US market
Serramend (Health Concerns), a food supplement au code-barres 810034441089, is described by its US market label, recorded on 25 September 2025. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 25 September 2025. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-00692.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Health Concerns
- Barcode
- 810034441089
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Rice Bran, Hypromellose
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Serratiopeptidase | Enzyme | 20 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Serramend
Entered into DSLD on 23 February 2022. En vente sur le marché américain (selon le DSLD).Same active composition.
Official label: Serramend
Entered into DSLD on 24 May 2017. En vente sur le marché américain (selon le DSLD).- Different quantity per serving : Serratiopeptidase: 10 mg in this version; 20 mg on the displayed label
Official label: Serramend
Entered into DSLD on 25 September 2013. Retirée du marché américain le 21 March 2017 (selon le DSLD).- Different quantity per serving : Serratiopeptidase: 10 mg in this version; 20 mg on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Health Concerns